Cargando…
Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome
INTRODUCTION: Allogeneic hematopoietic cell transplantation (HCT) was a standard therapy in chronic phase (CP) chronic myeloid leukemia (CML). As a result of the effective therapy with tyrosine kinase inhibitors (TKI), HCT was shifted to defined clinical situations. We present the results of observa...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569656/ https://www.ncbi.nlm.nih.gov/pubmed/26220759 http://dx.doi.org/10.1007/s00277-015-2457-1 |